PRTA Q1 2019 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$186,000-18.1% YoY

Gross Profit

-$13M-7048.4% margin

Operating Income

-$23M-12340.9% margin

Net Income

-$21M-11217.7% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

-4.1%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$460M

Total Liabilities

$147M

Stockholders' Equity

$312M

Cash & Equivalents

$410M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$186,000	$227,000	-18.1%
Gross Profit	-$13M	-$34M	+62.0%
Operating Income	-$23M	-$49M	+52.9%
Net Income	-$21M	-$49M	+57.2%